Ultra Market Research | Global Cancer Diagnostics Market
Global Cancer Diagnostics Market
Report ID : 898
Category : Pharmaceuticals,Global
No Of Pages : 125
Published on: December 2024
Status: Published
Format :
Key Question Answer
Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major players financial performance.
Evaluate strategies adopted by major players.
Recommendations
Global Cancer Diagnostics Market Introduction This industry of developing, manufacturing, and distributing diagnostic tools and technologies in order to detect the existence of cancer at either the early or advanced stages includes the tools of imaging, molecular diagnostics, biopsy techniques, and advanced genomic tools. Its growth has been notable lately with the increasing prevalence of cancer worldwide and the ever-rising demand for personalized medicine. Recent trends include advancements in liquid biopsy, AI-driven diagnostics, and next-generation sequencing. The market was valued at about USD 145 billion in 2023 and is expected to grow at a CAGR of 8.2% over the next decade due to technological innovation and healthcare awareness.
Segmentation Diagnostic Tools • Imaging Diagnostics o Radiology Systems MRI CT Scanners Others o Nuclear Imaging PET Scans SPECT o Ultrasound • Molecular Diagnostics o Polymerase Chain Reaction (PCR) Real-Time PCR Digital PCR o Next-Generation Sequencing (NGS) o Others • Biopsy Techniques o Needle Biopsy o Liquid Biopsy Circulating Tumor Cells (CTCs) Cell-Free DNA (cfDNA) o Surgical Biopsy
Applications • Breast Cancer Diagnostics o Imaging Tools Mammography Breast MRI o Biomarkers o Others • Lung Cancer Diagnostics o Imaging Tools o Molecular Testing EGFR Mutation Testing ALK Rearrangement Testing • Colorectal Cancer Diagnostics o Stool-Based Tests o Imaging and Colonoscopy o Molecular Testing
Drivers Increasing cancer incidence has become the most important global health challenge, which is driving the Global Cancer Diagnostics Market. Liquid biopsy and AI-integrated imaging systems have also added to the advancements in diagnostic technology, propelling the market further. Growing awareness about early detection of cancer and increasing investments in healthcare infrastructure in emerging economies are significant growth catalysts. The shift towards precision medicine and targeted therapies also increases demand for advanced diagnostic tools to ensure a personalized approach to cancer care.
Restraints Despite its growth, the Global Cancer Diagnostics Market still faces some challenges. High costs associated with advanced diagnostic technologies limit adoption in low-income regions. Moreover, strict regulatory requirements and lengthy approval processes hamper the timely introduction of new products. A lack of skilled healthcare professionals trained to operate sophisticated diagnostic systems further restricts market growth, especially in developing nations.
Opportunity Emerging markets have great growth opportunities for the Global Cancer Diagnostics Market. Increased healthcare funding and government initiatives promoting cancer awareness and screening programs drive market penetration. Technological advancement such as point-of-care testing and AI-based solutions are providing untapped potential for innovation. Biomarker-based assay development by diagnostic companies and research institutes also promises future growth.
Trend Latest trend in the Global Cancer Diagnostics Market is the integration of artificial intelligence and machine learning into diagnostic workflows. AI-powered tools improve diagnostic accuracy, reduce interpretation times, and enable personalized risk assessments. The adoption of non-invasive diagnostic techniques like liquid biopsy is gaining traction due to patient preference and cost-effectiveness. Digital pathology and telemedicine are emerging trends transforming the diagnostics landscape.
The market was valued at approximately USD 145 billion in 2023.
Rising cancer prevalence, technological advancements, and growing healthcare awareness.
High costs, regulatory hurdles, and lack of skilled professionals.
The market is expected to grow at a CAGR of 8.2% in the next decade.
AI-based diagnostics, liquid biopsy, and digital pathology.
1. Introduction 1.1 Report Description 1.2 Research Methodology 1.2.1 Data Mining 1.2.2 Market Modeling and Forecasting 1.2.3 Data Validation 1.2.4 Industry Analysis
2. Market Dashboard
3. Market Overview 3.1 Market Definition and Scope 3.2 Market Segmentation 3.2.1 By Diagnostic Tool • Imaging Diagnostics o Radiology Systems o Nuclear Imaging o Ultrasound • Molecular Diagnostics o PCR o NGS o Others • Biopsy Techniques o Needle Biopsy o Liquid Biopsy o Surgical Biopsy • Others 3.2.2 By Application • Breast Cancer Diagnostics • Lung Cancer Diagnostics • Colorectal Cancer Diagnostics • Others 3.2.3 By End-User • Hospitals • Diagnostic Laboratories • Research Institutes • Others 3.2.4 By Distribution Channel • Hospital Pharmacies • Retail Pharmacies • Online Pharmacies 3.2.5 By Geography 3.3 Market Dynamics 3.3.1 Drivers 3.3.2 Restraints 3.3.3 Opportunities 3.3.4 Challenges
4. Global Cancer Diagnostics Market by Diagnostic Tool 4.1 Introduction 4.2 Market Size and Growth Rate by Diagnostic Tool (2024–2030) 4.2.1 Imaging Diagnostics • Radiology Systems • Nuclear Imaging • Ultrasound 4.2.2 Molecular Diagnostics • PCR • NGS • Others 4.2.3 Biopsy Techniques • Needle Biopsy • Liquid Biopsy • Surgical Biopsy 4.2.4 Others
5. Global Cancer Diagnostics Market by Application 5.1 Introduction 5.2 Market Size and Growth Rate by Application (2024–2030) 5.2.1 Breast Cancer Diagnostics • Imaging Tools • Biomarkers • Others 5.2.2 Lung Cancer Diagnostics • Imaging Tools • Molecular Testing 5.2.3 Colorectal Cancer Diagnostics • Stool-Based Tests • Imaging and Colonoscopy • Molecular Testing 5.2.4 Others
6. Global Cancer Diagnostics Market by End-User 6.1 Introduction 6.2 Market Size and Growth Rate by End-User (2024–2030) 6.2.1 Hospitals • Cardiology Departments • Specialty Clinics 6.2.2 Diagnostic Laboratories • Independent Laboratories • Hospital-Affiliated Labs 6.2.3 Research Institutes
7. Global Cancer Diagnostics Market by Distribution Channel 7.1 Introduction 7.2 Market Size and Growth Rate by Distribution Channel (2024–2030) 7.2.1 Hospital Pharmacies • Inpatient Dispensing • Specialty Drug Distribution 7.2.2 Retail Pharmacies • Chain Pharmacies • Standalone Pharmacies 7.2.3 Online Pharmacies
8. Global Cancer Diagnostics Market by Geography 8.1 Introduction 8.2 Market Size and Growth Rate by Region (2024–2030) 8.2.1 North America • United States • Canada 8.2.2 Europe • Germany • France • United Kingdom • Rest of Europe 8.2.3 Asia Pacific • China • Japan • India • Southeast Asia • Rest of Asia Pacific 8.2.4 Latin America • Brazil • Rest of Latin America 8.2.5 Middle East & Africa (MEA) • GCC • North Africa • South Africa • Rest of MEA
10. List of Tables and Figures • Table 1: Global Cancer Diagnostics Market Segmentation • Table 2: Market Size by Diagnostic Tool (2024–2030) • Table 3: Market Size by Application (2024–2030) • Table 4: Market Size by End-User (2024–2030) • Table 5: Market Size by Distribution Channel (2024–2030) • Figure 1: Global Cancer Diagnostics Market Dynamics • Figure 2: Market Share by Region (2024) • Figure 3: Growth Rate Analysis by Diagnostic Tool • Figure 4: Competitive Landscape and Market Share
Research Methodology
The process of market research at Ultra Market Research is an iterative in application and usually follows following path. Information from secondary used to build data models, then results from data models are validated from primary participants. Then cycle repeats where, according to inputs from primary participants, additional secondary research is done, and new Information is again incorporated into data model. The process continues till desired level of Information is not generated
To calculate the market size, the report considers the revenue generated from the sales of Ultra Market Research providers. The revenue generated from the sales of Ultra Market Research has been calculated through primary and secondary research. The report also presents the key players operating in the Ultra Market Research market across the globe identified through secondary research and a corresponding detailed analysis of the top vendors in the market. The market size calculation also includes distribution channel segmentation determined using secondary sources and verified through primary sources.
Secondary Research
The secondary research source that are typically referred to include, but are not limited to:
Company websites, annual reports, financial reports, broker reports, investor presentations and SEC filings
Internal and external proprietary databases, relevant patent and regulatory databases
National government documents, statistical databases and market reports
News articles, press releases and web-casts specific to the companies operating in the market
The source for secondary research includes but is not limited to: Factiva, Hoovers and Statista
Inner Circle Represents – Stage of Research Process
Middle Circle Represents – Source of Information
Outer Circle Represents – Information Derived from that source
Primary Research We conduct primary interviews on an ongoing basis with industry participants and commentators in order to validate data and analysis. A typical research interview fulfills the following functions:
It provides first-hand Information on the market size, market trends, growth trends, competitive landscape, future outlook etc.
Helps in validating and strengthening the secondary research findings
Further develops the analysis team’s expertise and market understanding
Primary research involves E-mail interactions, telephonic interviews as well as face-to-face interviews for each market, category, segment and sub-segment across geographies
The participants who typically take part in such a process include, but are not limited to:
Industry participants: CEOs, VPs, marketing/ distribution channel managers, market intelligence managers and national sales managers
Purchasing managers, technical personnel, distributors and resellers
Outside experts: Investment bankers, valuation experts, research analysts specializing in specific markets
Key opinion leaders specializing in different areas corresponding to different industry distribution channels
Models Where no hard data is available, we use modeling and estimates in order to produce comprehensive data sets. A rigorous methodology is adopted in which the available hard data is cross referenced with the following data distribution channels to produce estimates:
Demographic data: Population split by segment
Macro-economic indicators: GDP, etc.
Industry indicators: Expenditure, distribution channel stage & infrastructure, sector growth and facilities.
Data is then cross checked by the expert panel.
2..1 Company Share Analysis Model
Company share analysis is used to derive the size of Global market. As well as study of revenues of companies for last three to five years also provide the base for forecasting the market size and its growth rate. This model is built in following steps: 2..2 Revenue Based Modeling
Revenue based models can be built in two ways – Top-Down or Bottom-Up irrespective of industry. Market size estimated from company share analysis acts as a validation point for bottom-up approach where as it acts as starting point for top-down approach.
2.1 Research Limitations Inflation is not a part of pricing in this report. Prices of Global Cancer Diagnostics Market and its derivatives vary in each region and hence similar revenue ratio does not follow for each individual region. The same price for each distribution channel has been taken into account while estimating and forecasting market revenue Globally. Regional average price has been considered while breaking down this market by application in each region. This report provides market size of Global Cancer Diagnostics Market for the past year and forecasts for the next six years. Global Cancer Diagnostics Market size is given in terms of revenue. Market revenue is defined in USD Million. Market numbers are given on the basis of different Global Cancer Diagnostics Market categories. Market size and forecasts for each major application is provided in the context of Global market. The numbers provided in this report are derived on the basis of demand for Global Cancer Diagnostics Market from different application industries in different regions.
Segmentation Diagnostic Tools • Imaging Diagnostics o Radiology Systems MRI CT Scanners Others o Nuclear Imaging PET Scans SPECT o Ultrasound • Molecular Diagnostics o Polymerase Chain Reaction (PCR) Real-Time PCR Digital PCR o Next-Generation Sequencing (NGS) o Others • Biopsy Techniques o Needle Biopsy o Liquid Biopsy Circulating Tumor Cells (CTCs) Cell-Free DNA (cfDNA) o Surgical Biopsy
Applications • Breast Cancer Diagnostics o Imaging Tools Mammography Breast MRI o Biomarkers o Others • Lung Cancer Diagnostics o Imaging Tools o Molecular Testing EGFR Mutation Testing ALK Rearrangement Testing • Colorectal Cancer Diagnostics o Stool-Based Tests o Imaging and Colonoscopy o Molecular Testing
